Evidence map›Paper›PMID 27411553›Full record

ArticleJournal of molecular modeling2016

Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A.

Shainaba A Saadhali, Sameer Hassan, Luke Elizabeth Hanna, Uma Devi Ranganathan, Vanaja Kumar

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shainaba A SaadhaliDepartment of Bacteriology, National Institute for Research in Tuberculosis, Chetpet, Chennai, 600031, India.
Sameer HassanDepartment of Biomedical Informatics, National Institute for Research in Tuberculosis, Chennai, 600031, India.
Luke Elizabeth HannaDepartment of Clinical Research, National Institute for Research in Tuberculosis, Chennai, 600031, India.
Uma Devi RanganathanDepartment of Bacteriology, National Institute for Research in Tuberculosis, Chetpet, Chennai, 600031, India.
Vanaja KumarDepartment of Bacteriology, National Institute for Research in Tuberculosis, Chetpet, Chennai, 600031, India. vanaja_kumar51@yahoo.co.in.
National Institute of Research in Tuberculosis · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacteriophages produce lysins that break down the host cell wall at the end of lytic cycle to release their progenies. The ability to lyse mycobacterial cells makes the lysins significant. Mycobacteriophage Che12 is the first reported temperate phage capable of infecting and lysogenising Mycobacterium tuberculosis. Gp11 of Che12 was found to have Chitinase domain that serves as endolysin (lysin A) for Che12. Structure of gp11 was modeled and evaluated using Ramachandran plot in which 98 % of the residues are in the favored and allowed regions. Che12 lysin A was predicted to act on NAG-NAM-NAG molecules in the peptidoglycan of cell wall. The tautomers of NAG-NAM-NAG molecule were generated and docked with lysin A. The stability and binding affinity of lysin A - NAG-NAM-NAG tautomers were studied using molecular dynamics simulations.

Indexed as

Molecular Docking SimulationMolecular Dynamics SimulationMycobacteriophagesMycobacterium tuberculosisPeptidoglycanStructural Homology, ProteinViral ProteinsPeptidoglycanViral ProteinsHomology modelingLysin AMolecular dynamics simulationMycobacteriophageMycobacterium tuberculosisPeptidoglycan

Identifiers

PMID27411553
OpenAlexW2472831450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.